Open access · CC-BY
via OpenAlex
Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment
Hao-Yu Zhao, Chu-Ying Yu, Xintong Ye, Suting Qian, Ye Huang, Qing-Sheng Liu
World Journal of Clinical Oncology · 2025
Abstract
Sirtuin 3 (SIRT3) is a primary mitochondrial deacetylase. Studies have confirmed that it directly activates mitophagy by modulating mitochondrial protein acetylation. As a key homeostatic mechanism, mitophagy activation alleviates oxidative stress-induced imbalance between cell proliferation and apoptosis, corrects stress-driven mitochondrial metabolic dysfunction, and thus inhibits excessive tumor growth, exerting significant antitumor effects. These functions establish SIRT3 as a key target for regulating mitophagy and cancer therapy. Clinically, strategies centered on its precise regulation may offer a novel direction for gastric cancer (GC) prevention and treatment, with selective activation remaining a critical challenge. SIRT3 could also serve as an auxiliary indicator in clinical guidelines for assessing tumor progression. Given this potential, this mini-review systematically examines SIRT3's mechanisms in regulating mitophagy, its role in GC pathogenesis, and translational prospects for targeting SIRT3 in GC management.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5306/wjco.v16.i12.111175
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Zhao, H., Yu, C., Ye, X., Qian, S., Huang, Y., & Liu, Q. (2025). Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment. <em>World Journal of Clinical Oncology</em>. https://doi.org/10.5306/wjco.v16.i12.111175
Vancouver
Zhao H, Yu C, Ye X, Qian S, Huang Y, Liu Q. Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment. World Journal of Clinical Oncology. 2025. doi:10.5306/wjco.v16.i12.111175.
BibTeX
@article{haoyu2025Releva,
title = {Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment},
author = {Hao-Yu Zhao and Chu-Ying Yu and Xintong Ye and Suting Qian and Ye Huang and Qing-Sheng Liu},
journal = {World Journal of Clinical Oncology},
year = {2025},
doi = {10.5306/wjco.v16.i12.111175},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Death and Disease 2014
Open access · CC-BY
Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
Frontiers in Cell and Developmental Biology 2023
Open access · CC-BY
New insight of the pathogenesis in osteoarthritis: the intricate interplay of ferroptosis and autophagy mediated by mitophagy/chaperone-mediated autophagy
Endocrinology 2020
Open access · CC0
Mitochondrial Dysfunction in Obesity and Reproduction
Frontiers in Cardiovascular Medicine 2024
Open access · CC-BY
Editorial: Cardiovascular inflammaging: basic and translational aspects
Cells 2026
Open access · CC-BY
Decoding Mitophagy in Breast Cancer: Biological Mechanisms, Dual Roles, and Clinical Implications
Translational Neurodegeneration 2026
Open access · CC-BY